Vitamin D deficiency and the risk of tuberculosis: A meta-analysis

Drug Design, Development and Therapy

Volumn 11, Issue , 2017, Pages 91-102

  Huang, Shao Jun ^a   Wang, Xian Hua ^b   Liu, Zhi Dong ^a   Cao, Wen Li ^c   Han, Yi ^a   Ma, Ai Guo ^b   Xu, Shao Fa ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^c Beijing Geriatric Hospital   (China)

Author keywords

25 hydroxyvitamin D; Meta analysis; Tuberculosis; Vitamin D; Vitamin D deficiency

Indexed keywords

VITAMIN D; ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT;

AFRICAN; ANTIRETROVIRAL THERAPY; ARTICLE; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFECTION RISK; LATENT TUBERCULOSIS; MEDLINE; META ANALYSIS (TOPIC); MIXED INFECTION; RISK FACTOR; TUBERCULOSIS; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WEB OF SCIENCE; BLOOD; HIV INFECTIONS; IMMUNOLOGY; META ANALYSIS;

ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; HIV INFECTIONS; HUMANS; RISK FACTORS; TUBERCULOSIS; VITAMIN D DEFICIENCY;

EID: 85007614064     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S79870     Document Type: Article

References (57)

1. Kim JH, Park JS, Cho YJ, et al. Low serum 25-hydroxyvitamin D level: an independent risk factor for tuberculosis? Clin Nutr. 2014; 33(6): 1081-1086.
2. Gibney KB, MacGregor L, Leder K, et al. Vitamin D deficiencyis associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis. 2008; 46(3): 443-446.
3. Chocano-Bedoya P, Ronnenberg AG. Vitamin D and tuberculosis. Nutr Rev. 2009; 67(5): 289-293.
4. Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in West London: a case-control study. Lancet. 2000; 355(9204): 618-621.
5. Wejse C, Olesen R, Rabna P, et al. Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr. 2007; 86(5): 1376-1383.
6. Ustianowski A, Shaffer R, Collin S, Wilkinson RJ, Davidson RN. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect. 2005; 50(5): 432-437.
7. Realegeno S, Modlin RL. Shedding light on the vitamin D-tuberculosis-HIV connection. Proc Natl Acad Sci U S A. 2011; 108: 18861-18862.
8. Liu PT, Stenger S, Li H, et al. Toll-like receptors triggering of a vitamin D mediated anti-microbical response. Science. 2006; 311(5768): 1770-1773.
9. Adams JS, Ren S, Liu PT, et al. Vitamin D directed rheostatic regulation of monocyte antibacterial responses. J Immunol. 2009; 182(7): 4289-4295.
10. Friis H, Range N, Pedersen ML, et al. Hypovitaminosis D is common among pulmonary tuberculosis patients in Tanzania but is not explained by the acute phase response. J Nutr. 2008; 138(12): 2474-2480.
11. Steenhoff AP, Redwood A, Pettifor JM, et al. Vitamin D status in HIV-infected patients with and without tuberculosis: a pilot study. J Acquir Immune Defic Syndr. 2012; 61(2): e21-e23.
12. Conesa-Botella A, Goovaerts O, Massinga-Loembé M, et al. Low prevalence of vitamin D deficiency in Ugandan HIV-infected patients with and without tuberculosis. Int J Tuberc Lung Dis. 2012; 16(11): 1517-1521.
13. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008; 37: (1)113-119.
14. Nansera D, Graziano FM, Friedman DJ, Bobbs MK, Jones AN, Hansen KE. Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis. Int J Tuberc Lung Dis. 2011; 15(11): 1522-1527.
15. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011], Section 7.7.3.5 Medians and interquartile ranges. The Cochrane Collaboration, 2011. Available from: http://handbook.cochrane.org/
16. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011], Section 7.7.3.6 Ranges. The Cochrane Collaboration, 2011. Available from: http://handbook.cochrane.org/
17. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011], Section 7.7.3.2 Obtaining standard deviations from standard errors and confidence intervals for group means. The Cochrane Collaboration, 2011. Available from: http://handbook.cochrane.org/
18. Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analysis. Ottawa, ON: Ottawa Health Research Institute; 2004.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177-188.
20. Higgins J, Thompson S, Deeks J, Altman D. Statistical heterogeneity in systematic reviews of clincial trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy. 2002; 7(1): 51-61.
21. Navarro-Mateu F, Escámez T, Koenen KC, Alonso J, Sánchez-Meca J. Meta-analyses of the 5-HTTLPR polymorphism and post-traumatic stress disorder. PLoS One. 2013; 8(6): e66227.
22. Davies PD, Brown RC, Woodhead JS. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax. 1985; 40(8): 187-190.
23. Grange JM, Davies PD, Brown RC, Woodhead JS, Kardjito T. A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle. 1985; 66(3): 187-191.
24. Davies PD, Church HA, Brown RC, Woodhead JS. Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis. 1987; 71(5): 341-344.
25. Davies PD, Brown RC, Church HA, Woodhead JS. The effect of anti-tuberculosis chemotherapy on vitamin D and calcium metabolism. Tubercle. 1987; 68(4): 261-266.
26. Davies PD, Church HA, Bovornkitti S, Charumilind A, Byrachandra S. Altered vitamin D homeostasis in tuberculosis. Int Med Thailand. 1988; 4: 45-47.
27. Chan TY, Poon P, Pang J, et al. A study of calcium and vitamin D metabolism in Chinese patients with pulmonary tuberculosis. J Trop Med Hyg. 1994; 97(1): 26-30.
28. Sasidharan PK, Rajeev E, Vijayakumari V. Tuberculosis and vitamin D deficiency. J Assoc Physicians India. 2002; 50: 554-558.
29. Yonemura K, Ohtake T, Matsushima H, Fujigaki Y, Hishida A. High ratio of 1,25-dihydroxyvitamin D3 to parathyroid hormone in serum of tuberculous patients with end-stage renal disease. Clin Nephrol. 2004; 62(3): 202-207.
30. Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn HJ. Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax. 2007; 62(11): 1003-1007.
31. Selvaraj P, Prabhu Anand S, Harishankar M, Alagarasu K. Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin d receptor and cathelicidin in pulmonary tuberculosis. J Clin Immunol. 2009; 29(4): 470-478.
32. Ho-Pham LT, Nguyen ND, Nguyen TT, et al. Association between vitamin D insufficiency and tuberculosis in a Vietnamese population. BMC Infect Dis. 2010; 10: 306.
33. Martineau AR, Leandro AC, Anderson ST, et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J. 2010; 35(5): 1106-1112.
34. Nielsen NO, Skifte T, Andersson M, et al. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. Br J Nutr. 2010; 104(10): 1487-1491.
35. Martineau AR, Nhamoyebonde S, Oni T, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci U S A. 2011; 108(47): 19013-19017.
36. Gray K, Wood N, Gunasekera H, et al. Vitamin D and tuberculosis status in refugee children. Pediatr Infect Dis J. 2012; 31(5): 521-523.
37. Koo HK, Lee JS, Jeong YJ, et al. Vitamin D deficiency and changes in serum vitamin D levels with treatment among tuberculosis patients in South Korea. Respirology. 2012; 17(5): 808-813.
38. Rathored J, Sharma SK, Singh B, et al. Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D. Int J Tuberc Lung Dis. 2012; 16(11): 1522-1528.
39. Chaudhary S, Thukral A, Tiwari S, Pratyush DD, Singh SK. Vitamin D status of patients with type 2 diabetes and sputum positive pulmonary tuberculosis. Indian J Endocrinol Metab. 2013; 17(Suppl 3): S670-S673.
40. Friis H, Range N, Changalucha J, et al. Vitamin D status among pulmonary TB patients and non-TB controls: a cross-sectional study from Mwanza, Tanzania. PLoS One. 2013; 8(12): e81142.
41. Iftikhar R, Kamran SM, Qadir A, Haider E, Bin Usman H. Vitamin D deficiency in patients with tuberculosis. J Coll Physicians Surg Pak. 2013; 23(10): 780-783.
42. Joshi L, Ponnana M, Penmetsa SR, Nallari P, Valluri V, Gaddam S. Serum vitamin D levels and VDR polymorphisms (BsmI and FokI) in patients and their household contacts susceptible to tuberculosis. Scand J Immunol. 2014; 79(2): 113-119.
43. Mastala Y, Nyangulu P, Banda RV, Mhemedi B, White SA, Allain TJ. Vitamin D deficiency in medical patients at a central hospital in Malawi: a comparison with TB patients from a previous study. PLoS One. 2013; 8(3): e59017.
44. Srinivasan A, Syal K, Banerjee D, et al. Low plasma levels of cholecalciferol and 13-cis-retinoic acid in tuberculosis: implications in host-based chemotherapy. Nutrition. 2013; 29(10): 1245-1251.
45. Gao WW, Wang Y, Zhang XR, et al. Levels of 1,25(OH)2D3 for patients with pulmonary tuberculosis and correlations of 1,25(OH)2D3 with the clinical features of TB. J Thorac Dis. 2014; 6(6): 760-764.
46. Hong JY, Kim SY, Chung KS, et al. Association between vitamin D deficiency and tuberculosis in a Korean population. Int J Tuberc Lung Dis. 2014; 18(1): 73-78.
47. Jubulis J, Kinikar A, Ithape M, et al. Modifiable risk factors associated with tuberculosis disease in children in Pune, India. Int J Tuberc Lung Dis. 2014; 18(2): 198-204.
48. Arnedo-Pena A, Juan-Cerdán JV, Romeu-Garcia A, et al. Latent tuberculosis infection, tuberculin skin test and vitamin D status in contacts of tuberculosis patients: a cross-sectional and case-control study. BMC Infect Dis. 2011; 11: 349.
49. Ganmaa D, Giovannucci E, Bloom BR, et al. Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial. Am J Clin Nutr. 2012; 96(2): 391-396.
50. Arnedo-Pena A, Juan-Cerdán JV, Romeu-García MA, et al. Vitamin D status and incidence of tuberculosis infection conversion in contacts of pulmonary tuberculosis patients: a prospective cohort study. Epidemiol Infect. 2015; 143(8): 1731-1741.
51. Conesa-Botella A, Meintjes G, Coussens AK, et al. Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome. Clin Infect Dis. 2012; 55(7): 1004-1011.
52. Tostmann A, Wielders JP, Kibiki GS, Verhoef H, Boeree MJ, van der Ven AJ. Serum 25-hydroxy-vitamin D3 concentrations increase during tuberculosis treatment in Tanzania. Int J Tuberc Lung Dis. 2010; 14(9): 1147-1152.
53. Fox GJ, Barry SE, Britton WJ, Marks GB. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2013; 41(1): 140-156.
54. Xia J, Shi L, Zhao L, Xu F. Impact of vitamin D supplementation on the outcome of tuberculosis treatment: a systematic review and meta-analysis of randomized controlled trials. Chin Med J (Engl). 2014; 127(17): 3127-3134.
55. Kim JH, Park JS, Cho YJ, et al. Low serum 25-hydroxyvitamin D level: an independent risk factor for tuberculosis? Clin Nutr. 2014; 33(6): 1081-1086 (Epub 2013 Nov 26).
56. Joshi L, Ponnana M, Penmetsa SR, Nallari P, Valluri V, Gaddam S. Serum vitamin D levels and VDR polymorphisms (BsmI and FokI) in patients and their household contacts susceptible to tuberculosis. Sand J Immunol. 2014; 79: 113-119 (Epub 2013).
57. Arnedo-Pena A, Juan Cerdan JV, Romeu-Garcia A, et al. Latent tuberculosis infection, tuberculin skin test and vitamin D status in contacts of tuberculosis patients: a cross-sectional and case-control study. BMC Infect Dis. 2011; 11: 349.